Posted On: 09/03/2014 5:12:20 AM
Post# of 30066
I have listened to snippets of the call (thanks Warp) and thanks to all here for the discussion. Big picture, things look to be on track and I like Icon as a partner.
Short term, the pps flip flops until we get bridge data and other concrete news that I hope to hear prior to Sept 22. Today's open will be interesting.
My gut and my head tells me that major news (multiple) must hit for us to get anywhere near a potential uplist by end of year and they are sitting on something big. I do not want to see anything more than a 1:10 split and would rather we remain on the OTC than do that. Revenue will start end of year/2015.
I do feel that milestones were too aggressive for this year in terms of timelines, but this is biotech and delays should be expected. Long and strong. The finish line to actual revs is in sight.
Short term, the pps flip flops until we get bridge data and other concrete news that I hope to hear prior to Sept 22. Today's open will be interesting.
My gut and my head tells me that major news (multiple) must hit for us to get anywhere near a potential uplist by end of year and they are sitting on something big. I do not want to see anything more than a 1:10 split and would rather we remain on the OTC than do that. Revenue will start end of year/2015.
I do feel that milestones were too aggressive for this year in terms of timelines, but this is biotech and delays should be expected. Long and strong. The finish line to actual revs is in sight.
(0)
(0)
